NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
4.240
+0.060 (1.44%)
At close: Jul 24, 2026, 4:00 PM EDT
4.210
-0.030 (-0.71%)
After-hours: Jul 24, 2026, 7:55 PM EDT

NextCure Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-56.1-57.62-59.75-67.64-75.91-70.77
Net Income
-54.66-55.84-55.65-62.72-74.73-69.39
Earnings Per Share
-17.19-19.65-23.88-27.00-32.28-30.12
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
29.7441.8268.62108.3159.91219.59
Total Debt
3.884.155.155.956.610
Net Cash (Debt)
25.8637.6763.47102.35153.31219.59
Net Cash Growth
-49.23%-40.65%-37.99%-33.24%-30.19%-21.57%
Net Cash Per Share
7.2513.2527.2344.1266.3195.42

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-49.98-49.61-40.81-52.97-53.89-57.28
Capital Expenditures
---0.47-0.82-2.12-2.36
Free Cash Flow
-49.98-49.61-41.28-53.79-56-59.64
Free Cash Flow Growth
------